Compare SSTI & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SSTI | SERA |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.3M | 90.6M |
| IPO Year | 2017 | 2021 |
| Metric | SSTI | SERA |
|---|---|---|
| Price | $6.59 | $3.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 205.8K | 36.9K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $102,749,000.00 | $95,000.00 |
| Revenue This Year | $4.97 | $217.92 |
| Revenue Next Year | $10.56 | $479.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.06 |
| 52 Week Low | $5.78 | $1.37 |
| 52 Week High | $19.43 | $9.13 |
| Indicator | SSTI | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 37.41 | 45.38 |
| Support Level | $5.78 | $2.81 |
| Resistance Level | $6.35 | $3.56 |
| Average True Range (ATR) | 0.45 | 0.28 |
| MACD | 0.15 | -0.01 |
| Stochastic Oscillator | 59.83 | 28.29 |
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.